Human interferon regulatory factor 2 gene : intron-exon organization and functional analysis of 5'-flanking regionYING CHA; DEISSEROTH, A. B.The Journal of biological chemistry (Print). 1994, Vol 269, Num 7, pp 5279-5287, issn 0021-9258Article

Effect of nucleotide concentration on specificity of sequence amplificationWEI ZHANG; DEISSEROTH, A. B.BioTechniques. 1991, Vol 11, Num 1, pp 60-62, issn 0736-6205, 2 p.Article

v-abl activates embryonic globin gene expression in mouse erythroleukemia cellsLOPEZ, A. R; BARKER, J; DEISSEROTH, A. B et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 7, pp 2042-2046, issn 0027-8424Article

Use of autotransplants in chronic myeloid leukaemiaGOLDMAN, J. M; DEISSEROTH, A. B.Bone marrow transplantation. Supplement (Basingstoke). 1992, Vol 10, Num 1, pp 74-76, issn 0951-3078Conference Paper

Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy modelHANANIA, E. G; DEISSEROTH, A. B.Clinical cancer research. 1997, Vol 3, Num 2, pp 281-286, issn 1078-0432Article

Interferon regulatory factor 1 induces the expression of the interferon-stimulated genesHENDERSON, Y. C; CHOU, M; DEISSEROTH, A. B et al.British journal of haematology. 1997, Vol 96, Num 3, pp 566-575, issn 0007-1048Article

OncologyDEVITA, V. T; DEISSEROTH, A. B.JAMA, the journal of the American Medical Association. 1996, Vol 275, Num 23, pp 1833-1834, issn 0098-7484Article

P53 gene mutations in acute myelogenous leukaemiaGUIYING HU; WEI ZHANG; DEISSEROTH, A. B et al.British journal of haematology. 1992, Vol 81, Num 4, pp 489-494, issn 0007-1048Article

Successful continuation of cisplatin therapy after partial recovery from acute renal failureWONG, D. C; DEISSEROTH, A. B.Cancer treatment reports. 1985, Vol 69, Num 6, pp 731-733, issn 0361-5960Article

Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitorsSARRIS, A. H; TALPAZ, M; DEISSEROTH, A. B et al.Leukemia. 1996, Vol 10, Num 5, pp 757-765, issn 0887-6924Article

Gene therapy of solid tumors and hematopoietic neoplasmsBACHIER, C. R; DEISSEROTH, A. B.Cancer treatment and research. 1997, Vol 77, pp 3-26, issn 0927-3042Article

Human embryonic ζ-globin gene expression in mouse-human hybrid erythroid cell linesHONG-YUAN LUO; DEISSEROTH, A. B; CHUI, D. H. K et al.Blood. 1995, Vol 86, Num 3, pp 1212-1217, issn 0006-4971Article

Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-α geneNEWELL, C. L; DEISSEROTH, A. B; LOPEZ-BERESTEIN, G et al.Journal of leukocyte biology. 1994, Vol 56, Num 1, pp 27-35, issn 0741-5400Article

Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia : A prospective studyKORNBLAU, S. M; ANDREEFF, M; BENEDICT, W. F et al.Clinical cancer research. 1998, Vol 4, Num 8, pp 1955-1963, issn 1078-0432Article

Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210^bcr-abl positive 32D myeloid leukemia cellsGUO, X.-Y. D; CUILLEROT, J.-M; TAO WANG et al.Oncogene (Basingstoke). 1998, Vol 17, Num 7, pp 825-833, issn 0950-9232Article

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma : the case for aggressive managementVAN BESIEN, K. W; KHOURI, I. F; ROMAGUERA, J. E et al.Journal of clinical oncology. 1995, Vol 13, Num 5, pp 1096-1102, issn 0732-183XArticle

p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiationWEI ZHANG; GRASSO, L; MCCLAIN, C. D et al.Cancer research (Baltimore). 1995, Vol 55, Num 3, pp 668-674, issn 0008-5472Article

Recent advances in the application of gene therapy to human diseaseHANANIA, E. G; KAVANAGH, J; HORTOBAGYI, G et al.The American journal of medicine. 1995, Vol 99, Num 5, pp 537-552, issn 0002-9343Article

High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemiaKANTARJIAN, H. M; TALPAZ, M; ANDERSSON, B et al.Bone marrow transplantation (Basingstoke). 1994, Vol 14, Num 1, pp 57-61, issn 0268-3369Article

Expression of unusual immunophenotype combinations in acute myelogenous leukemiaREADING, C. L; ESTEY, E. H; HUH, Y. O et al.Blood. 1993, Vol 81, Num 11, pp 3083-3090, issn 0006-4971Article

Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemiaCLAXTON, D. F; READING, C. L; NAGARAJAN, L et al.Blood. 1992, Vol 80, Num 3, pp 582-586, issn 0006-4971Article

RAS oncogene mutation are rare late stage events in chronic myelogenous leukemiaLEMAISTRE, A; MING-SHENG LEE; TALPAZ, M et al.Blood. 1989, Vol 73, Num 4, pp 889-891, issn 0006-4971Article

A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patientsMESSERSCHMIDT, G. L; MAKUCH, R; SHAN, T. C et al.Cancer. 1988, Vol 62, Num 4, pp 795-801, issn 0008-543XArticle

The hematopoietic toxicity of regional radiation therapy: correlations for combined modality therapy with systemic chemotherapyABRAMS, R. A; LICHTER, A. S; BROMER, R. H et al.Cancer. 1985, Vol 55, Num 7, pp 1429-1435, issn 0008-543XArticle

Allogeneic bone marrow transplantation for poor-prognosis lymphoma : Response, toxicity, and survival depend on disease histologyVAN BESIEN, K. W; MEHRA, R. C; MCCARTHY, P. L et al.The American journal of medicine. 1996, Vol 100, Num 3, pp 299-307, issn 0002-9343Article